News from the FDA/CDC
FDA/CDC
FDA panel unanimously endorses lecanemab for Alzheimer’s
An intravenous infusion targeting amyloid-beta, lecanemab received accelerated FDA approved earlier in 2023 for the treatment of early Alzheimer’s...
News from the FDA/CDC
FDA approves buprenorphine injection for opioid use disorder
Brixadi is approved in both weekly and monthly subcutaneous injectable formulations at varying doses.
News from the FDA/CDC
Overdose deaths mark another record year, but experts hopeful
“But these numbers are still extraordinarily high. We shouldn’t suggest the crisis is in any way over.”
News from the FDA/CDC
FDA moves to curb misuse of ADHD meds
The boxed warning will also advise heath care professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.
News from the FDA/CDC
FDA approves OTC naloxone, but will cost be a barrier?
“The major question is what is it going to cost. In order for people to access it they have to be able to afford it,”
News from the FDA/CDC
FDA moves to stop the spread of illicit ‘tranq’ in the U.S.
The agency “remains concerned about the increasing prevalence of xylazine mixed with illicit drugs,” said FDA Commissioner Robert M. Califf, MD....
Latest News
Teen girls report record levels of sadness, sexual violence: CDC
Nearly one-third of girls (30%) reported seriously considering suicide, up from 19% in 2011.
News from the FDA/CDC
New report says suicide rates rising among young Black people
Significant increases in suicide occurred among Native American, Black and Hispanic people.
News from the FDA/CDC
Massive rise in drug overdose deaths driven by opioids
The total number of deaths caused by drug overdose exceeded 100,000 for the first time ever in 2021.
News from the FDA/CDC
Alzheimer’s Association to CMS: Ditch restraints on amyloid drugs
The CMS coverage restrictions for anti-amyloid drugs were finalized in April on the...
News from the FDA/CDC
FDA puts REMS requirements on hold to ensure continuity of care
The FDA said it will temporarily not object if inpatient pharmacies dispense a days’ supply of clozapine that aligns with a patient’s monitoring...